Drug Shortage Report for TEVA-ZOLMITRIPTAN OD
Report ID | 161012 |
Drug Identification Number | 02342545 |
Brand name | TEVA-ZOLMITRIPTAN OD |
Common or Proper name | ZOLMITRIPTAN 2.5MG OD TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ZOLMITRIPTAN |
Strength(s) | 2.5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL ORAL |
Packaging size | P PACK 6 |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-03-18 |
Estimated end date | 2024-06-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-12-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2022-12-01 | French | Compare |
v15 | 2022-12-01 | English | Compare |
v14 | 2022-11-14 | French | Compare |
v13 | 2022-11-14 | English | Compare |
v12 | 2022-10-28 | French | Compare |
v11 | 2022-10-28 | English | Compare |
v10 | 2022-09-07 | French | Compare |
v9 | 2022-09-07 | English | Compare |
v8 | 2022-08-18 | French | Compare |
v7 | 2022-08-18 | English | Compare |
v6 | 2022-06-30 | French | Compare |
v5 | 2022-06-30 | English | Compare |
v4 | 2022-06-03 | French | Compare |
v3 | 2022-06-03 | English | Compare |
v2 | 2022-05-19 | French | Compare |
v1 | 2022-05-19 | English | Compare |
Showing 1 to 16 of 16